Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC decreased its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 33.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,739,202 shares of the company's stock after selling 869,539 shares during the quarter. Riverbridge Partners LLC owned 1.50% of Definitive Healthcare worth $17,288,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its holdings in shares of Definitive Healthcare by 12.6% in the 1st quarter. JPMorgan Chase & Co. now owns 4,910,312 shares of the company's stock worth $50,723,000 after buying an additional 548,630 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Definitive Healthcare by 6.2% in the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company's stock worth $34,609,000 after buying an additional 254,726 shares during the period. Brown Advisory Inc. lifted its holdings in shares of Definitive Healthcare by 0.7% in the 3rd quarter. Brown Advisory Inc. now owns 3,967,991 shares of the company's stock worth $31,704,000 after buying an additional 26,276 shares during the period. BlackRock Inc. lifted its holdings in shares of Definitive Healthcare by 59.0% in the 2nd quarter. BlackRock Inc. now owns 3,722,599 shares of the company's stock worth $40,949,000 after buying an additional 1,381,109 shares during the period. Finally, Fred Alger Management LLC lifted its holdings in shares of Definitive Healthcare by 10.1% in the 1st quarter. Fred Alger Management LLC now owns 2,526,320 shares of the company's stock worth $26,097,000 after buying an additional 232,588 shares during the period. Hedge funds and other institutional investors own 98.67% of the company's stock.

Definitive Healthcare Price Performance

DH traded down $0.09 during trading on Friday, hitting $7.92. The company's stock had a trading volume of 277,157 shares, compared to its average volume of 575,824. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20. Definitive Healthcare Corp. has a twelve month low of $5.53 and a twelve month high of $12.45. The business's fifty day simple moving average is $8.64 and its 200 day simple moving average is $8.33. The firm has a market capitalization of $932.34 million, a price-to-earnings ratio of -4.45, a P/E/G ratio of 7.35 and a beta of 1.39.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The firm had revenue of $65.93 million during the quarter, compared to analysts' expectations of $66.01 million. On average, equities research analysts forecast that Definitive Healthcare Corp. will post 0.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DH has been the subject of several recent research reports. Canaccord Genuity Group lowered Definitive Healthcare from a "buy" rating to a "hold" rating in a research report on Friday, January 5th. Stifel Nicolaus reduced their price target on Definitive Healthcare from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Wednesday, January 17th. Canaccord Genuity Group boosted their price target on Definitive Healthcare from $9.00 to $10.00 and gave the stock a "hold" rating in a research report on Thursday, February 29th. Needham & Company LLC lowered Definitive Healthcare from a "buy" rating to a "hold" rating in a research report on Wednesday, January 17th. Finally, Barclays boosted their price target on Definitive Healthcare from $10.00 to $11.00 and gave the stock an "equal weight" rating in a research report on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $11.31.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.